Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 35.55 INR
Change Today +2.50 / 7.56%
Volume 302.1K
PLEP On Other Exchanges
Symbol
Exchange
Natl India
As of 7:10 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

plethico pharmaceuticals ltd (PLEP) Snapshot

Open
35.50
Previous Close
33.05
Day High
36.20
Day Low
31.10
52 Week High
06/12/14 - 74.30
52 Week Low
03/30/15 - 24.20
Market Cap
1.2B
Average Volume 10 Days
101.9K
EPS TTM
36.01
Shares Outstanding
34.1M
EX-Date
09/22/11
P/E TM
1.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for PLETHICO PHARMACEUTICALS LTD (PLEP)

Related News

No related news articles were found.

plethico pharmaceuticals ltd (PLEP) Related Businessweek News

No Related Businessweek News Found

plethico pharmaceuticals ltd (PLEP) Details

Plethico Pharmaceuticals Limited engages in the manufacture, marketing, and distribution of pharmaceutical and allied healthcare products in the nutraceuticals and herbal segments in India and internationally. It provides nutraceutical products, such as dietary supplements under the Natrol brand; and sports nutrition products, including HSP protein supplement for enhanced training, Pro NOS whey protein, and Black Powder pre workout energy boosting formula, as well as Prolab and Coach’s Formula sports nutrition product. The company’s nutraceutical products also comprise flavored herbal teas under the Laci Le Beau brand; NuHair and Shen Min hair products containing a serum and vitamins targeted at combating hair loss; and Promensil for relief of menopause symptoms, as well as Trinovin for maintaining prostate and urinary health. In addition, it offers herbal healthcare products, including a range of herbal products for cough and sore throat in the drops, syrups, and lozenges forms under the Travisil brand; Mountain Herbz range of herbal medicines and supplements to treat high blood pressure, digestions, and aphrodisiacs; medicated lozenges sold under the Actifresh brand; Travopassit, an anti-stress product; and Byte and Myntz products. Further, the company provides anti-malarial, anti-tubercular, anti-infective, pain, cardiac, gastro, and cough and cold products. Plethico Pharmaceuticals Limited was founded in 1963 and is based in Mumbai, India.

Founded in 1963

plethico pharmaceuticals ltd (PLEP) Top Compensated Officers

Executive Chairman and Managing Director
Total Annual Compensation: 2.2M
Chief-Executive Officer, Whole-Time Director,...
Total Annual Compensation: 2.2M
Compensation as of Fiscal Year 2014.

plethico pharmaceuticals ltd (PLEP) Key Developments

Aurobindo Pharma and Plethico Pharmaceuticals Settle Dispute

Aurobindo Pharma and Plethico Pharmaceuticals settled a dispute related to the acquisition of Natrol. Aurobindo Pharma said that Plethico will pay it $23.3 million to settle a dispute related to the acquisition of Natrol. On April 6, 2015, Natrol LLC had approached the Delaware Bankruptcy Court with certain discrepancies and non- performance of obligations by erstwhile owner Plethico with regard to the deal. Based on the discussions, a settlement agreement has been reached, wherein Plethico Group would assign $23.3 million in cash in milestone payments, certain global IP rights and other assets. The acquisition included manufacturing assets, personnel, commercial infrastructure, including nutraceutical brands in USA of Natrol along with an agreement to take certain liabilities.

Plethico Pharmaceuticals Limited, Board Meeting, Mar 31, 2015

Plethico Pharmaceuticals Limited, Board Meeting, Mar 31, 2015. Agenda: To consider board changes; and to file an application before the concerned authorities seeking extension of time for repayment of deposits under Companies Act, 2013.

Plethico Pharmaceuticals Limited Announces Executive Changes

Plethico Pharmaceuticals Limited announced that the Board of Directors of the company at its meeting held on March 31, 2015, approved the appointment of Mr. Deen Bandhu Roy, as an additional Director, Mrs. Meena Matani, as an additional Director and Ms. Anuradha Kumari, as an additional Director of the company. The company also approved the resignation of Mr. Pramod K. Shrivastava as Director of the company, effective from the conclusion of this meeting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PLEP:IN 35.55 INR +2.50

PLEP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $46.54 USD -0.31
Amway Malaysia Hldgs Bhd 10.84 MYR -0.16
Endo International PLC $84.64 USD -0.03
GlaxoSmithKline PLC 1,515 GBp +14.00
Kellogg Co $63.01 USD -0.17
View Industry Companies
 

Industry Analysis

PLEP

Industry Average

Valuation PLEP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book 0.1x
Price/Cash Flow 3.6x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PLETHICO PHARMACEUTICALS LTD, please visit www.plethico.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.